Section Arrow
TRDA.NASDAQ
- Entrada Therapeutics
Quotes are at least 15-min delayed:2025/03/28 05:29 EDT
Last
 9.96
+0.06 (+0.61%)
Day High 
10.0607 
Prev. Close
9.9 
1-M High
12.505 
Volume 
89.23K 
Bid
3.99
Ask
15.93
Day Low
9.79 
Open
9.95 
1-M Low
9.745 
Market Cap 
372.19M 
Currency USD 
P/E 5.89 
%Yield -- 
10-SMA 10.54 
20-SMA 10.79 
50-SMA 12.08 
52-W High 21.79 
52-W Low 9.745 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.68/-4.95
Enterprise Value
423.83M
Balance Sheet
Book Value Per Share
11.40
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
210.78M
Operating Revenue Per Share
2.32
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OCEAOcean Biomedical0.078-0.0057-6.81%-- 
DRMADermata Therapeutics Inc.1.42+0.07+5.19%-- 
ONCOOnconetix Inc0.1077+0.0017+1.60%-- 
RGLSRegulus Therapeutics1.5+0.21+16.28%-- 
NKTXNkarta1.97+0.6+43.80%-- 
Quotes are at least 15-min delayed:2025/03/28 05:29 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.